Patrick Walsh
Corporate Officer/Principal presso IMMUNIC, INC.
Profilo
Patrick Walsh is currently the Chief Business Officer at Immunic, Inc. He previously worked as the Director of Business Development at Akebia Therapeutics, Inc. and as the Head of Corporate Development at AVEO Pharmaceuticals, Inc. Walsh received his undergraduate degree from Colby College and his graduate and Masters of Business Administration degrees from the University of Michigan.
Posizioni attive di Patrick Walsh
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNIC, INC. | Corporate Officer/Principal | 14/10/2021 |
Precedenti posizioni note di Patrick Walsh
| Società | Posizione | Fine |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Patrick Walsh
| Colby College | Undergraduate Degree |
| University of Michigan | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Patrick Walsh
